Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details a transaction by Daniel Barber, President and CEO of Aquestive Therapeutics, Inc. On June 15, 2026, Mr. Barber sold 25,000 shares of common stock at a weighted average price of $4.1604 per share. The transactions occurred within a price range of $4.14 to $4.235 per share. Following this sale, Mr. Barber holds 635,574 shares. The filing also includes a Power of Attorney document, appointing attorneys-in-fact to handle electronic filings with the SEC, including Forms 3, 4, and 5, and Form 144, on behalf of Mr. Barber.